Mankind ready to run until ADCOM

As we know Mankind's blockbuster Afrezza will be reviewed by ADCOM on April 1st followed by FDA decision on April 15. If ADCOM is positive FDA will most likely approve Afrezza. If you see the chart, SP is following the trendline. Major major support at 5.65. If you notice the volume today it certainly was something unusual. Smart money coming in? I don't know but someone knows something. Also look at the crossing MACD's and slow stochastics which is turning upwards. Along with a low RSI all signals point in one direction and that is up north. I see MNKD slowly rising to $8 by ADCOM which is a solid 40%. And if it gets an approval I see a short term PT of $18 and it will keep going up with news of a partner coming in.

Considering the best case scenario i see a PT of $27-30 by year end. That is a huge return on investment with a high RR ratio.

But also consider the risk which is the price going to $1 if it gets rejected by FDA.